Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cantourage Group SE Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €7.00 |
52 Week High | €13.80 |
52 Week Low | €5.86 |
Beta | 0 |
1 Month Change | -6.67% |
3 Month Change | -2.37% |
1 Year Change | -30.14% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -57.06% |
Recent News & Updates
Shareholder Returns
HIGH | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -2.1% | -0.4% | -1.3% |
1Y | -30.1% | -19.5% | 4.0% |
Return vs Industry: HIGH underperformed the German Pharmaceuticals industry which returned -19.5% over the past year.
Return vs Market: HIGH underperformed the German Market which returned 4% over the past year.
Price Volatility
HIGH volatility | |
---|---|
HIGH Average Weekly Movement | 7.7% |
Pharmaceuticals Industry Average Movement | 5.7% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.6% |
10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: HIGH has not had significant price volatility in the past 3 months.
Volatility Over Time: HIGH's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | n/a | n/a | www.cantourage.com |
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.
Cantourage Group SE Fundamentals Summary
HIGH fundamental statistics | |
---|---|
Market cap | €87.29m |
Earnings (TTM) | -€969.38k |
Revenue (TTM) | €5.22m |
0.0x
P/S Ratio0.0x
P/E RatioIs HIGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HIGH income statement (TTM) | |
---|---|
Revenue | €5.22m |
Cost of Revenue | €3.38m |
Gross Profit | €1.83m |
Other Expenses | €2.80m |
Earnings | -€969.38k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did HIGH perform over the long term?
See historical performance and comparison